1. Latest News
  2. Submit Press Release

COPD: Novel Therapeutics and Management Strategies

Understanding current clinical trial guidelines for COPD and emphasis on new therapies and issues surrounding the management of COPD and management of exacerbations of COPD

June 13, 2012 - PRLog -- SMi is proud to present their 4th annual conference on COPD. With presentations from the biggest players in the field, this year’s event promises to be a perfect forum for discussion and debate with key opinion leaders from industry and academia.

Key Benefits of Attending:
•  Hear from leading industry professionals on the current clinical trials process and
rapid proof of concept studies
Consider developments in the modelling and management of exacerbations of COPD
•  Evaluate unique complexities of COPD pathophysiology - compare and contrast
COPD with Asthma to improve your understanding of what makes COPD unique and
needing of particular attention
•  Develop combination and oxygen therapies within COPD - learn about triple
therapies and novel therapies within the treatment of COPD
•  Analyse all phases of the discovery process, from pre-clinical modelling, phase 2
studies all the way through to modelling clincal outcomes
•  Network with and learn from key industry professionals and research leading academics
•  Discuss the latest in health economics for COPD drugs with internationally recognized key opinion leaders

For more information visit http://www.smi-online.co.uk/goto/copd-conference19.asp or call Ninica Hussain on +44 0207 827 6186 email nhussain@smi-online.co.uk

--- End ---

Click to Share

Contact Email:
***@smi-online.co.uk Email Verified
Source:SMi Group
Location:United Kingdom
Tags:Copd, Exacerbation, Inhale, Lung, Asthma
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

Like PRLog?
Click to Share